ClinicalTrials.Veeva

Menu

Biomarkers of Acute Kidney Injury in Cardiac Surgery (AKIrisk)

N

Nikola Bradic, MD

Status

Unknown

Conditions

Acute Kidney Injury (Nontraumatic)

Study type

Observational

Funder types

Other

Identifiers

NCT03830450
University North

Details and patient eligibility

About

Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI risk. Because of that, today different biomarkers are investigated to predict incidence for development AKI after cardiac surgery. This investigation will try to find potentially risk patients for developing AKI after cardiac surgery by using conventional markers (creatinine, glomerular filtration rate) in perioperative period comparing with two different biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and growth differentiation factor 15 (GDF-15) which are proven markers in patients with increased risk for AKI development.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients scheduled for cardiac surgery (CABG, valve replacement/repair, combined)
  • older than 18 years

Exclusion criteria

  • previous known renal disease
  • patients on chronic dialysis

Trial contacts and locations

0

Loading...

Central trial contact

Nikola Bradic, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems